tiếng anh giao tiếp tập 2 Danh mục: Báo cáo khoa học
... men) 21 50 ± 12 (24 -76) 70 ± 13 (47-97) 10% 30 50 ± 12 (22 -71) 72 ± 15 (47-104) 20 % 21 53 ± 11 (25 -68) 69 ± 18 (43-108) 10% 28 52 ± (38-76) 75 ± 22 (47- 120 ) 21 % 100 51 ± 11 (22 -76) 72 ± 17 (43- 120 ) ... Tender joint count 21 .3 ± 12. 3 (6- 62) 21 .4 ± 13.1 (5-58) 23 .2 ± 16.8 (4-63) 24 .1 ± 13.4 (6-53) 22 .5 ± 13.7 (4-63) FACIT-F (0- 52) 26 ± 11 (4-50) 26 ± 10 (4-50) 27 ± 12 ( 12- 50) 26 ± 11 (4-50) SF-36 ... interleukin-16 Visvanathan et al Arthritis Research & Therapy 20 10, 12: R211 http://arthritis-research.com/content/ 12/ 6/R211 22 23 24 25 26 27 28 29 30 Page 11 of 11 expression in synovial fibroblasts...
Danh mục: Báo cáo khoa học
... 84.4 46 .2 43.3 66.8 24 .9 50.7 37 .2 69.3 30.3 57.1 34 .2 69.1 27 .5 63.4 30.1 74 .2 42. 5 64.1 26 .7 70.1 52. 2 39.0 49.8 61 .2 38.3 52. 4 38.5 61.5 38.4 40 .2 28.9 62. 4 75.6 12. 5 11.9 64.0 20 .9 15.1 62. 4 ... 0. 32 (0.41) 0.09 (0 .25 ) 0.10 (0 .25 ) 0.16 (0. 32) 0 .27 (0.39) 0.43 (0.45) 0.30 (0. 42) 0 .27 (0.40) 0.16 (0. 32) 0.05 (0.18) 0.07 (0 .22 ) 0.07 (0 .23 ) 0.08 (0 .23 ) 0.04 (0.17) 0.05 (0.19) 0.07 (0 .22 ) ... 0.00 02 < 0.0001 < 0.0001 < 0.0001 1.658 0.5 72 0.974 1 .26 1 1.663 1.157 1 .23 7 1.034 0.746 1.018 0.965 4.956 2. 097 8.630 0.944 1. 120 1.145 1 .23 2 to 2. 2 32 0 .24 3 to 1.343 0.701 to 1.3 52 0.9 12 to 1.744...
Danh mục: Báo cáo khoa học
... Repopulation 8. 62 n.d 1.56 9 .20 5.06 n.d 93.9 1 .24 6.65 Recovery 11.9 2. 45 1 .24 22 .7 4.49 65 .2 2 .21 5.50 12 months after repopulation 1. 62 40.9 6.46 24 months after repopulation APRIL (ng/ml) 0.04 ... 3. 42 0. 92 0.75 1.33 1.31 1.90 2. 30 1.08 4 .27 7.90 n.d 2. 62 n.d 4.06 3. 12 3.51 4.41 months post-treatment 5.88 6.34 4.46 2. 83 1.59 Baseline 409 77.8 189 5.04 96.7 124 179 23 .7 39.5 Depletion 4 12 ... S14 S16 S17 S19 S20 27 /F 56/F 33/F 50/F 33/F 33/F 19/F 35/F 56/F 51/F Baseline 25 14 12 22 14 12 Depletion 11 13 10 n.d 16 11 12 n.d months post-treatment 11 13 n.d n.d Baseline 2 15 18 8 Depletion...
Danh mục: Báo cáo khoa học
... 5,634 21 ,580 1 ,24 6 72, 539 42, 536 2, 156,097 184,713 163,435 11,869
Danh mục: Hóa học - Dầu khí
... 100 Male 62 61 Female 39 39 Median age (years range) 63 (26 -80) Gender Performance Status 79 78 20 20 >1 2 Colon 79 78 Rectum 22 22 Liver metastases 79 78 77 76 >1 24 24 43 42 1 -2 40 40 >2 18 18 ... 3.15) 0.03 2. 20 (1.03 4.70) 0.04 Number of Lines: II-III vs I 2. 20 (1 .25 - 3.89) 0.01 4.60 (1.87 11.31) 0.001 EGFR score: 0-1 vs 2- 3 2. 27 (1.35 - 3. 82) 0.0 02 1.99 (0.89 4.44) 0.09 - - 2. 14 (0.97 ... Cetuximab CPT-11 19 19 CPT-11, L-OHP, 5-FU 29 29 FOLFIRI 21 21 FOLFOX 20 20 Only Cetuximab 12 12 Campanella et al Journal of Translational Medicine 20 10, 8:36 http://www.translational-medicine.com/content/8/1/36...
Danh mục: Y học thưởng thức
... 26 (4) Lesion length, 21 (3) mme Type of lesion, No (%) A (3) Bı 52 (45) B2 12 (10) C 49 ( 42) Paclitaxelb (n:101) P Valuec 76 (75) (9) 16 (16) 67.4 (7.3) 31 (5) 369 056 506 28 (8) 22 (7) 2 (2) ... drug-eluting http://www.medsci.org Int J Med Sci 20 11, 12 13 14 15 16 17 18 19 20 21 22 23 73 versus bare-metal stents J Am Coll Cardiol, 20 06; 48: 25 84– 25 91 Mauri L, Hsieh WH, Massaro JM, Ho KK, ... Glucose 127 .2 ( 62. 7) Paclitaxelb (n:101) 58 (10 .2) P Valuec 36 (36) 64 (63) 55 (54) 69 (68) (7) (6) (3) 34 (34) 47 (47) 20 (20 ) 5 23 3.8 (57.4) 150.3 (48.4) 39.4 (8.3) 158.6 (101 .2) 114.7 (46.4) 5 2...
Danh mục: Sức khỏe người cao tuổi
... -4.6 36 45.7 822 1413 X2 =14.1 53 -1.9 -2. 9 to -0.9 26 58 17 47.6 0.7 -1.1 to 2. 5 17 60 23 15 48.8 1 .2 0.4 to 2. 0 15 64 21 489 44.4 -3.6 -5 .2 to -2. 0 33 1746 45 .2 -2. 9 -3.7 to -2. 1 27 58 50.3T ... to -3.4 28 63 Nonelderly Prepaid (HMO) 1413 727 45.8 (0.5) -1 .2 -2. 6 to 0 .2 23 X 2= 2.3 62 16 46.9 (0.6) 1.5 0.1 to 2. 9 12 X z =2. 6 68 Fee-for-service 686 45.6 (0.5) -2. 4 -3.8 to -1.0 29 57 15 ... Nonpoverty 22 35 45.0 Average Scores -3.0 Baseline* 4-y At 48.5 1.1 Categorical Change, %t 95% CI§ Worse Same Better 15 63 22 0.0 to 2. 4 14 X2 =1 3_ 64 22 -0.4 to 2. 4 16 63 21 0.3 to 1.9 11 X24.3 43.5§...
Danh mục: Sức khỏe giới tính
... Ͻ0.001 2. 5 (1.4–4.6) 455 51 (11 .2) 32 10 (31 .2) 3.6 (1.5–8.5) Ͻ0.01 4.8 (2. 0–11.6) 403 49 ( 12. 2) 100 13 (13.0) 1.1 (0.5 2. 2) 22 4 27 ( 12. 1) 27 9 35 ( 12. 5) 1.0 (0.6–1.8) 24 1 33 (13.7) 24 8 27 (10.9) ... 39 (11.6) 1 .2 (0.7 2. 3) P value aOR (95%CI) 0.1 0 .2 0.7 0.5 26 0 19 (7.3) 22 6 41 (18.1) 2. 8 (1.5–5 .2) Ͻ0.001 326 30 (9 .2) 160 30 (18.8) 2. 3 (1.3–4.1) Ͻ0.01 329 28 (8.5) 1 62 32 (19.8) 2. 6 (1.5–4.7) ... 2 , 3ϩ Initial weight Ͻ 42 kg у 42 kg Relapse n (%) 380 52 (13.7) 123 10 (8.1) OR (95%CI) 1.8 (0.8–3.9) 26 1 27 (10.3) 24 2 35 (14.5) 1.5 (0.8 2. 6) 20 9 24 (11.5) 27 7 36 (13.0) 1 .2 (0.6 2. 1) 150 21 ...
Danh mục: Hóa học - Dầu khí
... [36.4] [28 .6] 49 55 Gender Age (median) paraprotein subtype G 0.99 [27 .3] [64.3] [9.1] [21 .4] D [18 .2] [0] LC [45.5] [14.3] I & II [63.6] [50] III [36.4] [50] [27 .3] [57.1] [ 72. 7] [ 42. 9] No [9.1] ... author declares that they have no competing interests Received: 27 July 20 10 Accepted: 26 November 20 10 Published: 26 November 20 10 References Chim CS, Hwang YY, Pang C, Shek TW: Restoration ... [45.5] [28 .6] [54.5] 10 [71.4] [27 .3] [7.1] ISS stage ≥VGPR after induction No Yes 0.69 0 .22 7 ≥VGPR after ABMT 0.03 Oligoclonal reconstitution Yes no DAPK methylation methylated 0.434 0 .21 6 unmethylated...
Danh mục: Hóa học - Dầu khí
... Female 31 38.7 36 42 45.0 52. 5 2 2.5 Cardia 21 26 .3 Body 18 22 .5 Antrum/pylorus 41 51 .2 Liver Lung 26 21 32. 5 26 .3 Peritoneum 19 23 .8 Others 14 17.4 G1 2. 5 G2 26 32. 5 G3 52 65.0 treatment response ... Translational Medicine 20 10, 8: 126 http://www.translational-medicine.com/content/8/1/ 126 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 versus best supportive care (BSC) as 2nd-line chemotherapy ... 0.889 0.308 0. 929 0. 525 2% 0.500 0.889 0.340 0.940 0.588 3% 0.645 0.889 0. 421 0.9 52 0.700 4% 0. 823 0.889 0.593 0.9 62 0.838 5% 0.887 0.889 0.696 0.965 0.888 6% 0.887 0.778 0.667 0.9 32 0.863 Treatment...
Danh mục: Hóa học - Dầu khí
... 116 (27 %) 53 (28 %) 63 (26 %) years 76 (17%) 31 (16%) 45 (18%) years years 143 (56%) 83 ( 32% ) 70 (56%) 40 ( 32% ) 73 (55%) 43 ( 32% ) years 61 (24 %) 27 (22 %) 34 (26 %) years 43 (17%) 17 (14%) 26 (19%) ... IIC 27 (6%) 10 (5%) 17 (7%) IIIA, IIIB 82 (19%) 26 (14%) 56 (23 %) IIIC IV 27 7 (64%) 49 (11%) 136 (71%) 19 (10%) 141 (58%) 30 ( 12% ) 87 (20 %) 35 (18%) 52 (21 %) ≤ cm 141 ( 32% ) 77 (40%) 64 (26 %) ... 1.0 IV - 2. 76 [1.44,5 .27 ] 0.0 02 Residual tumour size 1.0 1.0 ≤ cm 1 .23 [1 .22 ,4.07] 0.009 2. 23 [1.06,4.67] 0.033 > cm 3.41 [1.88,6.18] 0.000 2. 99 [1.45,6.17] 0.003 Grade Grade 1.0 2. 92 [1.45,5.86]...
Danh mục: Hóa học - Dầu khí
... and long terminal repeat sequences over years in vivo and in vitro J Virol 1991, 65 :22 5 -23 1 22 23 24 25 26 27 28 Fitzgibbon JE, Mazar S, Dubin DT: A new type of G > A hypermutation affecting human ... E44D (0) K219Q (7.8) Q151M (3.9) T215F (11.7) T215Y (33.3) RT (NNRTI) (n = 12) V108I (25 ) Y181C (33.3) G190S (0) P236L (0) Y188C (0) V106A (0) K103N (9.6) Y188H/L (16.6) M230L (0) P 225 H (0) L100I ... CG GC K20R (2. 9) I47V (2. 9) L10F (0) V82A/S (17.6) I47V (0) L10I (17.6) L10R (5.8) G48V (11.7) L24I (0) K20M (2. 9) L10V (5.8) M46L (0) D30Na (14.7) I50V (0) L90M (47) M46L (17.6) I54M (2. 9) G73S...
Danh mục: Hóa học - Dầu khí
... (2. 9-4.8) [24 .7%] 350 [68.9%] 22 5 [29 .6%] 74.6 (54.7-98) 78 129 66.7 (51.3-76.7) [89.4%] 92 [117.9%] 85 [65.9%] 57 [73.1%] 70 [54.3%] 25 .3 (20 .6 -29 .5) [ 92% ] 20 .3 (11 -25 ) [91%] 674 [ 122 .3%] 53 [59.6%] ... 31.3 (26 .5-40.5) [67.5%] 21 0 [56.8%] 47 [39.8%] 22 .1 (16.7 -28 .2) [47.6%] 20 7 [55.9%] 53 [44.9%] B (superscan) 15.0 (13 .2- 17 .2) 508 761 16.0 (11.9 -21 .1) [106.7%] 459 [90.4%] 3 32 [43.6%] 3.7 (2. 9-4.8) ... 607 [110 .2% ] 50 [56 .2% ] 27 3 [107.5%] 406 [103.3%] 38 .2 (26 .5-46.9) [51 .2% ] 30.7 (21 .1-59.4) [111.6%] 18.8 (9.8 -24 .8) [84.3%] 29 8 [117.3%] 29 0 [73.8%] C3, L1, L5, L femur, R tibia C (6 -20 L1, L3,...
Danh mục: Báo cáo khoa học
... 31 (20 .5) 21 (20 .8) 2 = 0.144 27 (17.9) 21 (20 .8) 63 (41.7) 42 (41.6) 82 (54.3) 23 (15 .2) 56 (55.4) 21 (20 .8) 20 (13 .2) (7.9) 26 (17 .2) 16 (15.8) 108 (71.5) 28 (18.5) 79 (78 .2) 17 (16.8) 2 = ... 6.1 9 .2 22. 9 2 = 1.033 P = 31 27 .7 54.5 8.9 6.3 22 .4 66 .2 20.4 17.7 7.4 8.6 6.5 2 = 1.703 P = 19 16.5 65.8 2 = 0. 428 P = 51 54.8 13.9 22 .8 2 = 0.678 P = 41 7.5 91.5 90 .2 8.5 9.8 2 = 0 .26 5 ... ( 42. 88) 32. 28 (43.53) Bodily pain 38.10 (29 . 72) 39 .25 (29 .36) t = −0 .23 1 P = 82 t = 0.306 P = 76 General health 38.06 (23 . 02) 37.08 (23 .48) t = −0.333 P = 74 Vitality 43.06 (25 .21 ) 42. 43 (25 .14)...
Danh mục: Báo cáo khoa học
... 0 .22 0.30 0 .27 0 .25 0 .23 0 .22 0 .2 0 .28 0 .23 0 .24 0 .27 0.35 0.33 0 .24 0 .24 0 .24 0 .22 0 .28 0.16 0 .28 0 .29 0 .26 0 .26 F M F F M F F F F 2. 72 2.61 2. 03 2. 44 2. 60 2. 07 2. 78 1.76 2. 43 2. 38 2. 1 3. 42 ... 3.51 2. 19 3.01 2. 11 2. 47 1.91 1.76 1.88 1.94 1. 82 1. 72 2 .21 2. 95 3.03 2. 31 2. 72 2.34 1.76 2. 36 1.51 2. 14 2. 52 2 .23 2. 35 6.67 10.1 9.97 7.94 9.98 8 .28 7.93 9.56 7.04 7.8 7.16 8.40 8.53 9.11 9. 52 ... 1.88 2. 53 2. 77 1.89 2. 93 2. 27 2. 40 9.16 8.17 8.56 9.93 7.84 9 .26 8.35 7 .26 7.75 8.48 10.13 10.53 7.48 8.19 7.51 10.39 9.79 8.01 7 .23 8.81 0.30 0. 32 0 .24 0 .25 0.33 0 .22 0.33 0 .24 0.31 0 .28 0 .21 ...
Danh mục: Báo cáo khoa học
... 13.7 (2. 5–41.0) 36 (1–85) 11.3 (5.5–19 .2) 12. 2 (8.1 29 .7) DAS28 at baselinea 5.3 (2. 4–8.1) 5.9 (3.7–7.5) HAQ at baselinea 1.4 (0.4 2. 8) 1.6 (0.3 2. 8) Monotherapy/combination therapy 5 /27 3/14 ... No 32 Age (years)a 56.7 (23 .5–80.9) Female/male Duration of disease 25 /7 (years)a Serum CRP at baseline (mg/l)a Serum COMP at baseline (u/l)a 12. 9 (3.0–55.5) 20 (1–84) Etanercept 17 55.3 (23 .2 70.4) ... trial Ann Intern Med 20 02, 136:1- 12 Correspondence Tore Saxne, Department of Rheumatology, Lund University Hospital, S -22 1 85 Lund, Sweden Tel: +46 46 171 627 ; fax: +46 46 128 468; e-mail: tore.saxne@reum.lu.se...
Danh mục: Báo cáo khoa học
... treatment (n) 2. 78 ± 1.41 2. 70 ± 2. 70 0.47 Swollen joint count (0 28 ) 4.57 ± 3.16 4.55 ± 2. 70 0.43 Tender joint count (0 28 ) 9 .21 ± 5.78 8.35 ± 6.07 0.80 DAS28 score 5.33 ± 1. 12 5.31 ± 1.19 0.76 ... 37.59 ± 23 .18 37.45 ± 23 .71 0.91 CRP (mg/l) 26 .93 ± 24 .87 31.30 ± 27 .24 0.65 Values are expressed as mean ± standard deviation CRP, C-reactive protein; DAS28, Disease Activity Score 28 ; DMARD, ... 0.97) Similar results were observed with p55 (25 34 ± 1074 pg/ml versus 24 36 ± 953 pg/ml; P = 0.57) and p75 (3054.8 ± 673.8 pg/ml versus 23 32. 2 ± 921 .3 pg/ml; P = 0.84) soluble receptors in good...
Danh mục: Báo cáo khoa học
... (22 .7) 23 (57.5) 57 (37.5) 2. 25 (1.11–4.58) Low/Low 22 4 (65.3) 12 (30.0) 75 (49.7) Referent Low/High 68 (19.8) 22 (55.0) 44 (29 .1) 3.13 (1.41–6. 92) 0.005 4 .20 (1.66–10.63) 0.0 02 High/Low 41 ( 12. 0) ... -1,0 82 IL-10 Low (AA/AG) 29 2 (85.1) 34 (85.0) 119 (78.8) Referent Referent High (GG) 51 (14.9) (15.0) 32 (21 .2) 0.66 (0 .25 –1.70) Low (GG) 26 5 (77.3) 17 ( 42. 5) 95 ( 62. 5) Referent High (AA/GA) 78 (22 .7) ... None/NSAIDS (26 .1) 17 (73.9) (17.4) 19 ( 82. 6) Antimalarials 23 (57.5) 17 ( 42. 5) (15.0) 34 (85.0) Corticosteroids (28 .6) 20 (71.4) (22 .2) 21 (77.8) Antimalarials and corticosteroids 25 (41.7) 35...
Danh mục: Báo cáo khoa học
... -2. 5 -2. 4 0.66§ 0.0 02 Diarrhea Grade I 17 (55) 29 (91) Grade II, III 14 (45) (9) 0.03¶ Anti diarrhea drug used No 21 (68) 29 (91) Yes 10( 32) 3(9)
Danh mục: Báo cáo khoa học
... 0.759-8.995 0. 128 V35 2. 313 0.751-7. 122 0.144 V40 2. 485 0 .29 2 -21 .1 52 0.405 V45 1 .21 9 0.373-14.146 0.475 V50 1.613 0 .22 9 -22 . 824 0.318 V55 1.446 0 .21 5 -20 .061 0.594 V60 1.139 0.070-18.6 12 0. 527 COPD 0.154 ... 1.835-56. 024 0.008 MLD 3.199 0.196- 52. 380 0.415 V5 4. 024 0.765 -21 .163 0.100 V10 9. 023 1.910- 42. 625 0.005 V15 4. 024 0.765 -21 .163 0.100 V20 2. 801 0.834-9.403 0.096 V25 3. 423 0.713-16. 421 0. 124 V30 2. 613 ... 6.03 x = 28 . 02, SD = 7.09 0.0 02 V25 12. 96% (5.90 -26 .26 %) x = 12. 88, SD = 4. 42 x = 20 .91, SD = 6.98 0.001 V30 10.00% (4.68 -21 .43%) x = 9. 72, SD = 3.45 x = 15.69, SD = 6.00 0.008 V35 9. 92% (3.89-18.65%)...
Xem thêm